Naltrexone Poa Pharma (Naltrexone Hydrochloride)

Naltrexone Hydrochloride acts as a competitive antagonist at mu, kappa, and delta opioid receptors. By occupying these receptors without activating them, it prevents endogenous and exogenous opioids from producing their usual euphoric and reinforcing effects, thereby diminishing cravings and the risk of relapse.

The specific dose and dosing schedule are determined by the prescribing clinician based on the individual’s medical condition, treatment goals, and response. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Naltrexone Hydrochloride in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Naltrexone is an oral opioid antagonist with a long half‑life, offering convenient once‑daily dosing for many patients. Compared with injectable antagonists such as naloxone, it provides sustained receptor blockade but requires adherence to oral administration and may have a different side‑effect profile.

Store the product at room temperature, below 25 °C, in its original packaging. Protect it from excess moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Naltrexone Poa Pharma is taken orally, typically as a tablet swallowed with water. The exact timing relative to meals or other medications should follow the prescriber’s guidance to optimize absorption and minimize gastrointestinal discomfort.

Serious risks include hepatotoxicity, severe depression or suicidal thoughts, and rare allergic reactions such as anaphylaxis. Patients should be monitored regularly for liver function abnormalities and changes in mood, and any severe symptoms should prompt immediate medical evaluation.

Naltrexone is contraindicated in individuals with acute hepatitis, severe liver impairment, or those currently dependent on opioid analgesics without prior detoxification, as it can precipitate withdrawal. It should also be used with caution in patients with a history of severe depression.